Press Release Forum [pressreleaseforum.com] Forum Index

Press Release Forum [pressreleaseforum.com]
Free Press Release Distribution

A site of EPR Network

 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 

Real Time Press Release Distribution is here. Try it out, it's free!

 

Astral Pharmaceutical Industries Vadodara, India Will Enter

 
Post new topic   Reply to topic    Press Release Forum [pressreleaseforum.com] Forum Index -> Pharmaceuticals Press Releases
View previous topic :: View next topic  
Author Message
EPR Network
Site Admin


Joined: 31 Jan 2006
Posts: 32054

PostPosted: Sat Jul 24, 2010 4:42 am    Post subject: Astral Pharmaceutical Industries Vadodara, India Will Enter Reply with quote

Astral Pharmaceutical Industries Vadodara, India Will Enter United States Market Very Soon





Released on: July 24, 2010, 3:40 am
Author: Astral Pharmaceutical Industries, Vadodara, India
Industry: Pharmaceuticals

Astral Pharmaceutical Industries, a state of the art, manufacturing facility for Sterile Antibiotic powder injectables, at Vadodara, India is a specialized and dedicated site ,having independent manufacturing infrastructure for Cephalosporin and Penicillin Range of powder Injectable Drug Products.

The company headed by President & CEO Dr. Dushyant R. Patel has highly successful track record of more than a decade ,catering to the domestic, LATAM, SEA and CIS markets for the powder injectable drug products. Astral is a leading player in this segment and has been associated with MNCís and large Indian Pharma companies. Both the manufacturing lines, one for Cephalosporin Injectable Drug Products and other for Penicillin range of injectable Drug Products have been recently granted approval by US FDA. Prior to the facility approval from USFDA Astral has received several Regulatory accreditation such as HPFBI-Canada, TGA-Australia, MCC-South Africa, ANVISA-Brazil over and above accreditation from several Semi regulated countries.

Astral will soon be entering the US market in strategic alliance with Chicago based Sagent Pharmaceutical Inc. with whom more than 15 ANDAs have been filed.

While the development projects for more ANDAís are in pipeline, Astral is actively working on consolidating its strong regulatory profile for entry into EU markets apart from fast tracking its filings for Canada, Australia and New Zealand markets.

Continuous technology up gradation and focused development in the core competency area of sterile manufacturing operations has been the strategy of growth. Astral is poised to expand its operations in the field of specialized and niche sterile dosage forms for critical care segments and hospital products.

For further information visit http://www.astralpharma.com or contact Dr. Dushyant Patel at dushyantpatel@astralpharma.com.

Contact Details: Astral Pharmaceutical Industries
911, G.I.D.C., Makarpura. Vadodara-390010, Gujarat, INDIA.
Phone: +91 - 265 - 2638063, 2636630
Cell Phone: +91 982 404 3973
Fax: +91 - 265 - 2632212
Website: http://www.astralpharma.com
Email: dushyantpatel@astralpharma.com
Back to top
View user's profile Send private message
Display posts from previous:   
Post new topic   Reply to topic    Press Release Forum [pressreleaseforum.com] Forum Index -> Pharmaceuticals Press Releases All times are GMT - 4 Hours
Page 1 of 1

 
Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum

Submit Press Release (Free)Submit Press Release

 

 
Editor's pick: